7.8
CVE-2018-14787
- EPSS 0.06%
- Published 22.08.2018 18:29:00
- Last modified 21.11.2024 03:49:47
- Source ics-cert@hq.dhs.gov
- Teams watchlist Login
- Open Login
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Data is provided by the National Vulnerability Database (NVD)
Philips ≫ Intellispace Cardiovascular Version <= 3.1
Zu dieser CVE wurde keine CISA KEV oder CERT.AT-Warnung gefunden.
Type | Source | Score | Percentile |
---|---|---|---|
EPSS | FIRST.org | 0.06% | 0.174 |
Source | Base Score | Exploit Score | Impact Score | Vector string |
---|---|---|---|---|
nvd@nist.gov | 7.8 | 1.8 | 5.9 |
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
|
nvd@nist.gov | 4.6 | 3.9 | 6.4 |
AV:L/AC:L/Au:N/C:P/I:P/A:P
|
CWE-269 Improper Privilege Management
The product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.